Adaptive Biotechnologies News

Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE

Nov 19 18:51 ET

Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rubric Capital Management LP(9.76%),David Rosen(9.76%)

Nov 13 16:36 ET

Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matrix Capital Management Company LP(0.44%),David E. Goel(0.44%)

Nov 13 09:03 ET

Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.21%)

Nov 12 13:35 ET

Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Nikko Asset Management Americas, Inc.(5.24%)

Nov 8 15:20 ET

Adaptive Biotechnologies | 10-Q: Q3 2024 Earnings Report

Nov 7 16:38 ET

Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

Nov 7 16:24 ET

Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sumitomo Mitsui Trust Group, Inc. (“SMTG”)(5.24%),Nikko Asset Management Co., Ltd. (“NAM”)(5.24%)

Nov 5 06:11 ET

Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(7.21%)

Nov 4 10:59 ET

Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(6.4%),Millennium Group Management LLC(6.4%), etc.

Oct 11 16:19 ET

Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer BOBULSKY SUSAN

Oct 10 17:50 ET

Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Stacy L

Aug 23 16:32 ET

Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 22 16:20 ET

Adaptive Biotechnologies | 10-Q: Q2 2024 Earnings Report

Aug 1 16:32 ET

Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

Aug 1 16:20 ET

Adaptive Biotechnologies | 8-K: Current report

Jun 11 16:19 ET

Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%), etc.

May 28 16:32 ET

Adaptive Biotechnologies | DEFA14A: Others

May 24 12:06 ET

Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE

May 17 18:38 ET

Adaptive Biotechnologies | 10-Q: Q1 2024 Earnings Report

May 7 16:39 ET